Inspire Medical Systems (NYSE:INSP – Get Free Report) had its price objective cut by stock analysts at Stifel Nicolaus from $210.00 to $170.00 in a research note issued on Monday, Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 19.23% from the stock’s current price.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.